Sfoglia per RIVISTA
ONCOLOGY
Collezione AO Cuneo
Items : 5
Why Oncologists Should Feel Directly Involved in Persuading Patients with Head and Neck Cancer to Quit Smoking. in Oncology / Oncology. 2023;101(4):252-256. doi: 10.1159/000528345. Epub 2022 Dec 20.
2023
AO Cuneo
Bossi P; Garrone O; Galizia D; Abbona A; Paccagnella M; Minei S; Merlano MC; Denaro N;
Phase III Randomized Study of Induction Chemotherapy Followed by Definitive Radiotherapy + Cetuximab Versus Chemoradiotherapy in Squamous Cell Carcinoma of Head and Neck: The INTERCEPTOR-GONO Study (NCT00999700). in Oncology / Oncology. 2020;98(11):763-770. doi: 10.1159/000507733. Epub 2020 Jul 6.
2020
AO Cuneo
Merlano MC; Denaro N; Vecchio S; Licitra L; Curcio P; Benasso M; Bagicalupo A; Numico G; Russi E; Corvo' R; Bruzzi P;
Lenvatinib Long-Term Responses in Refractory Thyroid Cancer: Our Mono-Institutional Real-Life Experience with the Multidisciplinary Approach and Review of Literature. in Oncology / Oncology. 2019;97(4):206-210. doi: 10.1159/000501691. Epub 2019 Aug 7.
2019
AO Cuneo
Merlano MC; Borretta G; Corrado L; Bramardi F; Cesario F; Latina A; Denaro N;
State-of-the-art and emerging treatment options in the management of head and neck cancer: news from 2013. in Oncology / Oncology. 2014;86(4):212-29. doi: 10.1159/000357712. Epub 2014 May 10.
2014
AO Cuneo
Denaro N; Russi EG; Adamo V; Merlano MC;
The role of antiangiogenic agents in the treatment of head and neck cancer. in Oncology / Oncology. 2012;83(2):108-16. doi: 10.1159/000339542. Epub 2012 Jul 9.
2012
AO Cuneo
Denaro N; Russi EG; Colantonio I; Adamo V; Merlano MC;